Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Nimbus Therapeutics
25 First Street, Suite 404
Cambridge, MA 02141
Phone: 857-999-2009
http://www.nimbustx.com/

Nimbus Therapeutics harnesses the power of computational chemistry to design breakthroughs for the treatment of substantial and underserved human diseases. The company's focus on metabolic diseases, cancer and immune-inflammatory disorders is driven by its selection of well validated targets that have proven intractable to the approaches taken by others in the pharmaceutical and biotechnology industry. Using its unique approach and technological capabilities, Nimbus is rapidly progressing highly selective and potent small molecules through discovery and development.

Key Contact
Name
Donald Nicholson
Title
CEO
Funding Events

Date
Amount
Type
Investors
Valuation
03/18/15 $43,000,000 Series B Atlas Venture
Bill Gates
Lightstone Ventures
Pfizer Strategic Investments Group
SR One
undisclosed
06/05/18 $65,000,000 Venture Atlas Venture
Bill Gates
Lightstone Ventures
Pfizer Venture Investments
Schrodinger, Inc
SR One
undisclosed
10/15/20 $60,000,000 BVF Partners
RA Capital Management
undisclosed
07/15/21 $105,000,000 Access Biotechnology
Atlas Venture
BVF Partners
Commodore Capital
Logos Capital
RA Capital Management
Surveyor Capital
undisclosed
09/12/22 $125,000,000 Access Biotechnology
Atlas Venture
Bain Capital Life Sciences
Bill Gates
BVF Partners
Lightstone Ventures
Pfizer Venture Investments
RA Capital Management
SR One
SV Health Investors
undisclosed
09/18/23 $210,000,000 Atlas Venture
Bain Capital Life Sciences
BVF Partners
Gates Frontier
GV
Lightstone Ventures
Pfizer Venture Investments
RA Capital Management
SR One
SV Health Investors
undisclosed